Inventor
SHAN BEI
US38 patents
⚠️ This page may combine multiple inventors who share the name “SHAN BEI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
TULARIK INC
16 patentsUS6316503B1Nov 13, 2001
LXR modulators
TULARIK INC100 citations96
US6777446B2Aug 17, 2004
FXR modulators
TULARIK INC47 citations94
US6284923B1Sep 4, 2001
Substituted benzene compounds as antiproliferative and cholesterol lowering action
TULARIK INC24 citations92
US5880151AMar 9, 1999
Pentafluorobenzenesulfonamides and analogs
TULARIK INC25 citations92
US6465258B1Oct 15, 2002
FXR receptor-mediated modulation cholesterol metabolism
TULARIK INC26 citations86
US6482860B1Nov 19, 2002
Pentafluorobenzenesulfonamides and analogs
TULARIK INC14 citations83
US6316484B1Nov 13, 2001
Pentafluorobenzenesulfonamides and analogs
TULARIK INC13 citations81
US6121304ASep 19, 2000
Pentafluorobenzenesulfonamides and analogs
TULARIK INC12 citations81
US6962929B2Nov 8, 2005
Pentafluorobenzenesulfonamides and analogs
TULARIK INC6 citations73
US6388131B2May 14, 2002
Benzene compounds as antiproliferative and cholesterol lowering agents
TULARIK INC10 citations73
US6555326B1Apr 29, 2003
Nuclear hormone receptor fluorescence polarization assay
TULARIK INC8 citations72
US6566089B1May 20, 2003
Cell-based drug screens for regulators of gene expression
TULARIK INC9 citations71
US6297019B1Oct 2, 2001
Recombinant polynucleotides encoding CYP7 promoter-binding factors
TULARIK INC1 citations62
US6027901AFeb 22, 2000
CYP7 promoter-binding factors
TULARIK INC2 citations62
US5958697ASep 28, 1999
Isolated nucleic acids encoding CYP7 promoter-binding factors
TULARIK INC2 citations62
US6821750B2Nov 23, 2004
ABCG8 vectors, host cells, and method of making
TULARIK INC3 citations61
AMGEN INC
13 patentsUS8030457B2Oct 4, 2011
Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)
AMGEN INC175 citations99
US9056915B2Jun 16, 2015
Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)
AMGEN INC20 citations96
US8981064B2Mar 17, 2015
Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)
AMGEN INC20 citations96
US6906069B1Jun 14, 2005
LXR modulators
AMGEN INC18 citations93
US9493576B2Nov 15, 2016
Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)
AMGEN INC2 citations73
US7033810B2Apr 25, 2006
Sitosterolemia susceptibility gene (SSG): compositions and methods of use
AMGEN INC6 citations72
US7138418B2Nov 21, 2006
Pentafluorobenzenesulfonamides and analogs
AMGEN INC2 citations62
US7101681B1Sep 5, 2006
Nuclear hormone receptor drug screens
AMGEN INC3 citations61
US7662376B2Feb 16, 2010
Sitosterolemia susceptibility gene (SSG): compositions and methods of use
AMGEN INC0 citations51
US7229816B2Jun 12, 2007
Sitosterolemia susceptibility gene (SSG) polypeptides
AMGEN INC0 citations51
US9006408B2Apr 14, 2015
Modified lecithin-cholesterol acyltransferase enzymes
AMGEN INC0 citations48
US7511043B2Mar 31, 2009
FXR modulators
AMGEN INC0 citations48
US7105313B2Sep 12, 2006
Cell-based drug screens for regulators of gene expression
AMGEN INC1 citations47
JACKSON SIMON MARK
3 patentsUS8168762B2May 1, 2012
Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)
JACKSON SIMON MARK101 citations98
US9045547B2Jun 2, 2015
Methods of using antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)
JACKSON SIMON MARK42 citations96
US9920134B2Mar 20, 2018
Monoclonal antibodies to proprotein convertase subtilisin kexin type 9 (PCSK9)
JACKSON SIMON MARK13 citations90